Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on November 2, 2006

Stroke. 2006
Published online before print November 2, 2006, doi: 10.1161/01.STR.0000248836.82538.ee
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/12/3035    most recent
01.STR.0000248836.82538.eev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallenbeck, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallenbeck, J.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Vascular Diseases
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Acute coronary syndromes
Right arrow Cerebrovascular disease/stroke
Right arrow Arterial thrombosis
Right arrow Other Treatment
Right arrow Other Vascular biology
Right arrow Acute Stroke Syndromes

Submitted on June 1, 2006
Revised on July 19, 2006
Accepted on August 2, 2006

Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart. Workshop Summary

John Hallenbeck MD*; Gregory del Zoppo MD; Tom Jacobs PhD; Antoine Hakim MD, PhD; Stephen Goldman PhD; Ursula Utz PhD; Ahmed Hasan MD, PhD; for the Immunomodulation Workshop Participants

From the Stroke Branch (J.H.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md; Department of Molecular and Experimental Medicine (G.d.Z.), Scripps Research Institute, La Jolla, Calif; National Institute of Neurological Disorders and Stroke (T.J., U.U.), National Institutes of Health, Bethesda, Md; Canadian Stroke Network (A. Hakim), Ottawa, Ontario, Canada; and the National Heart, Lung, and Blood Institute (S.G., A. Hasan), National Institutes of Health, Bethesda, Md.

* To whom correspondence should be addressed. E-mail: hallenbj{at}ninds.nih.gov.

Abstract--This workshop examined the opportunities for translational research directed at immune and inflammatory mechanisms. This summary presents the background data in 3 general areas: (1) inflammation and hemostasis in cerebrovascular and cardiovascular disease, (2) immune interactions in the central nervous system and heart, and (3) translation of immune modulation in the brain and heart, all of which supported a consensus derivation of the opportunities for future research in these areas. The summary concludes with 11 recommendations.


Key words: acute stroke • cerebrovascular disease • immunology • inflammation • ischemia • stroke




This article has been cited by other articles:


Home page
StrokeHome page
A. M. Hakim
Vascular Disease: The Tsunami of Health Care
Stroke, December 1, 2007; 38(12): 3296 - 3301.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Z. Lee, Z. Xue, Y. Zhu, G.-Y. Yang, and W. L. Young
Matrix Metalloproteinase-9 Inhibition Attenuates Vascular Endothelial Growth Factor-Induced Intracerebral Hemorrhage
Stroke, September 1, 2007; 38(9): 2563 - 2568.
[Abstract] [Full Text] [PDF]